SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-14-007982
Filing Date
2014-11-12
Accepted
2014-11-12 16:09:01
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0914_immucell.htm 10-Q 510659
2 CERTIFICATIONS f10q0914ex31_immucell.htm EX-31 10715
3 CERTIFICATION f10q0914ex32_immucell.htm EX-32 5614
10 GRAPHIC image_002.gif GRAPHIC 12762
  Complete submission text file 0001213900-14-007982.txt   3223414

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE iccc-20140930.xml EX-101.INS 389239
5 XBRL SCHEMA FILE iccc-20140930.xsd EX-101.SCH 30082
6 XBRL CALCULATION FILE iccc-20140930_cal.xml EX-101.CAL 40189
7 XBRL DEFINITION FILE iccc-20140930_def.xml EX-101.DEF 54324
8 XBRL LABEL FILE iccc-20140930_lab.xml EX-101.LAB 246315
9 XBRL PRESENTATION FILE iccc-20140930_pre.xml EX-101.PRE 168113
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 141214058
SIC: 2835 In Vitro & In Vivo Diagnostic Substances